the aid library

LIST OPTIONS

Filter

13007

Download (97)

View PDF (159)

WHO recommendations HIV testing by lay providers

World Health Organization (WHO) World Health Organization (WHO) (2015) C_WHO

HIV testing Policy Brief July 2015

Download (206)

View PDF (190)

WHO recommends countries move away from the use of western blotting and line immunoassays in HIV testing strategies and algorithms. Policy brief

World Health Organization WHO (2019) C_WHO

WHO recommends replacing western blotting and line immunoassays with simpler tests in HIV testing services. These simpler tests include rapid diagnostic tests (RDTs) that can be used at the point-of-care, and enzyme immunoassays (EIAs). These tests get results to the client faster, produce accura... more

Download (214)

View PDF (263)

Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases
recommended

World Health Organization WHO (2020) C_WHO

The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing of patients who meet the definition of suspected case of pneumonia associated with a novel coronavirus identified in Wuhan, China. 19 March 2020

Consolidated guidelines on HIV testing services - 5Cs: consent, confidentiality, counselling, correct results and connection

World Health Organization (WHO) World Health Organization (WHO) (2015) C_WHO

Guidelines HIV testing services July 2015

HIV testing in Europe - Evaluation of the impact of the ECDC guidance on HIV testing: increasing uptake and effectiveness in the European Union

European Centre for Disease Prevention and Control (ECDC) European Centre for Disease Prevention and Control (ECDC) (2016) C2

Technical Report

Des tests de diagnostic moléculaire de l'infection à VIH destinés à améliorer l'access à la mesure de la charge virale et au diagnostic du VIH chez le nourrisson

Organisation Mondiale de la Santé OMS (2019) C_WHO

L’expansion de la mise en œuvre des approches de suivi du traitement par la réalisation de tests de mesure de la charge virale et de tests de diagnostic chez le nourrisson sera indispensable pour garantir la qualité des soins et des traitements ainsi que le succès des programmes. Le fait de ch... more

Download (101)

View PDF (149)

Diagnostic testing for SARS-CoV-2: interim guidance, 11 September 2020

World Health Organization WHO (2020) C_WHO

Available in Arabic, Chinese, English, French, Portuguese and Spanish https://apps.who.int/iris/handle/10665/334254

Download (125)

View PDF (149)

Диагностическое тестирование для определения вируса SARS-CoV-2

World Health Organization WHO (2020) C_WHO

В этом документе представлены временные рекомендации для лабораторий и других заинтересованных сторон, принимающих участие в диагностической работе для выявлен... more

Diagnostic test for lymphatic filariasis to support decisions for stopping triple-therapy mass drug administration: target product profile

World Health Organization WHO (2021) C_WHO

TARGET PRODUCT PROFILE

Download (303)

View PDF (288)

Diagnostic test for surveillance of lymphatic filariasis: target product profile

World Health Organization WHO (2021) C_WHO

The purpose of this TPP is to communicate the minimum and ideal characteristics desired to meet the need for discriminating low levels of risk for transmission, i.e. targeted prevalence thresholds in the surveyed areas. An in vitro diagnostic test is needed for the detection of analyte(s) specific t... more

Download (136)

View PDF (286)

Integration of HIV testing and linkage in family planning and contraception services: implementation brief

World Health Organisation (WHO) (2021) C_WHO

This implementation brief addresses integration of HIV testing services into family planning (FP) services. It is intended as a practical resource for national health programmes seeking to introduce or scale up HIV testing and linkage to HIV prevention, sexually transmitted infection, and antiretrov... more

External Link

Antigen-Tests auf SARS-CoV-2 zur professionellen Anwendung

Paul-Ehrlich-Institu PEI (2022) CC

25 März 2022

External Link

Collection testing and transfusion kit 2021 (CTT kit 2021)

World Health Organization WHO (2021) C_WHO

To provide supply & equipment to collect, test and transfuse 50 blood bags. The new Collection testing and transfusion kit 2021 is specially designed for emergency settings where blood transfusion is crucial. It contains all the necessary supply & equipment needed to collect blood, test it agains... more

Download (162)

View PDF (251)

Laboratory testing for the monkeypox virus
recommended

World Health Organization (WHO) (2022) C_WHO

Any individual that meets the suspected case definition of monkeypox should be offered testing in appropriately equipped laboratories by staff trained in the relevant technical and safety procedures. Confirmation of monkeypox virus infection is based on nucleic acid amplification testing (NAAT), usi... more

Download (242)

View PDF (243)

Laboratory testing for severe acute hepatitis of unknown aetiology in children: interim guidance, 17 June 2022

World Health Organization WHO (2022) C_WHO

This document provides interim guidance to countries on testing considerations and strategies for suspect cases of severe acute hepatitis of unknown aetiology in children. It is primarily intended for clinical, programmatic, laboratory and diagnostic stakeholders across Member States and national pu... more

Download (185)

View PDF (170)

The mhGAP community toolkit: field test version

World Health Organization WHO (2019) CC

The mhGAP community toolkit: field test version is an integral part of WHO's Mental Health Gap Action Programme (mhGAP), and aims at scaling up services for people with mental health conditions to achieve universal health coverage. The toolkit provides guidance for programme managers on how to i... more

Prediabetes Risk Test

adapted from Bang et al., Ann Intern Med (2009) American Diabetes Association in collaboration with the Centers for Disease Control and Prevention (CDC) (2024) CC2

The "Prediabetes Risk Test" is a tool designed to help individuals assess their risk for prediabetes and type 2 diabetes. The test uses a point-based system with questions about age, gender, family history of diabetes, history of high blood pressure, physical activity level, and weight category. Bas... more

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Download (1670)

View PDF (1790)

Basic Tests for Drugs - Pharmaceutical substances, medicinal plant materials and dosage forms

World Health Organization (1998) C_WHO

This manual has been designed to be used in conjunction with two earlier WHO publications, "Basic tests for pharmaceutical substances" (1986) and "Basic tests for pharmaceutical dosage forms" (1991). Most of the pharmaceutical substances and dosage forms covered are included in the WHO Model List of... more

Download (117)

View PDF (182)

Diagnostic tests in the management of seizures and altered consciousness in children

World Health Organization WHO (2015) C_WHO

Mental health

Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases recommended

Laboratory testing for the monkeypox virus recommended

Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases
recommended

Laboratory testing for the monkeypox virus
recommended